Thursday, January 03, 2019

Investorideas.com Newswire - The #AIEye: Medtronic (NYSE: $MDT) and IBM Watson (NYSE: $IBM) Announce New Feature for Predicting Low Glucose, @IBMWatson

Investorideas.com Newswire - The #AIEye: Medtronic (NYSE: $MDT) and IBM Watson (NYSE: $IBM) Announce New Feature for Predicting Low Glucose, @IBMWatson



The #AIEye: Medtronic (NYSE: $MDT) and IBM Watson (NYSE: $IBM) Announce New Feature for Predicting Low Glucose, @IBMWatson

Deep Learning Market to Reach $18 Billion at CAGR of 41% by 2023


Point Roberts, WA and Vancouver, BC - January 3, 2019 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI), in partnership with Gopher Protocol's (OTCQB: GOPH). Avant!, the latest innovation in machine learning, brings you today's edition of The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence.
Listen to today's podcast:

The #AI Eye: Medtronic (NYSE: $MDT) and IBM Watson (NYSE: $IBM) Announce New Feature for Predicting Low Glucose , @IBMWatson

Today's Column - The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Deep Learning Market to Reach $18 Billion at CAGR of 41% by 2023

A report from Market Research Future finds that the Deep Learning Market will reach $18 billion USD and exhibit a compound annual growth rate (CAGR) of 41 percent in the forecast period of 2017-2023. The report summary indicates that key drivers in the market include the increased popularity of AI and:
"...the growth of the market is also attributed to increasing adoption of advanced technologies such as IoT, big data analytics, and cloud computing, and rising concerns about data security across various industry verticals. Rising variety of mobile malware attacks is further fuelling the growth of global deep learning market."

Medtronic and IBM Watson Announce New Feature for Predicting Low Glucose and CEVA Tech Licensed and Deployed by Nordic Semiconductor

Stocks discussed: (NYSE:MDT) (NYSE:IBM) (NasdaqGS:CEVA)

Medtronic (NYSE:MDT) and its strategic technology partner IBM (NYSE:IBM) today announced a new feature for the Sugar.IQ personal diabetes assistant app called IQcast. AI technology from IBM Watson Health enables IQcast to predict the likelihood of an individual experiencing a low glucose event within an upcoming 1-4 hour window. Dr. Lisa Latts, deputy chief health officer at IBM Watson Health said:
"Hypoglycemia, or `going low`, is one of the most acute and frightening events that a person living with diabetes can experience. Fueled by the right data, AI and machine learning can play a powerful role in helping to alleviate the burden of diabetes and the worry of a hypoglycemic event, and we`ve built the new IQcast features with this goal in mind."
CEVA, Inc. (NasdaqGS:CEVA), a leading licensor of signal processing platforms and artificial intelligence processors, today announced that Nordic Semiconductor has licensed and deployed CEVA DSP technology in its nRF91® System-on-Chip (SoC) for low power cellular IoT connectivity. Michael Boukaya, vice president and general manager of the wireless business unit at CEVA, said:
"We are pleased to see Nordic Semiconductor address the burgeoning cellular IoT market with a compelling product offering powered by our DSP technology. We have a long and successful history in cellular, with our DSPs powering billions of cellular devices spanning terminals and infrastructure. Cellular IoT design wins for products like the nRF91 Series help to further expand our market reach into new and exciting areas."
Sam Mowers, Investorideas.com
For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member
Gopher Protocol's (OTCQB: GOPHAvant! is the latest innovations in machine learning and is targeted to empower Gopher Protocol's wide range of IoT and mobile technologies. Avant! can be integrated into wide range of applications in a variety of fields among these are business, medicine, engineering, analytics and more. Avant! learns and enhances its expertise based on wide range of data sources and on its own. www.avant-ai.com.
AI expert Dr. Danny Rittman, CTO of Gopher Protocol Inc. (OTCQB: GOPH) is a semiconductor designer with over twenty years of experience with companies such as Intel (NasdaqGS: INTC), DEC, IBM (NYSE:IBM), and Qualcomm (NasdaqGS: QCOM). He has worked on many prestigious Integrated Circuits projects, among them the Intel's Pentium Pro, DEC's Alpha chip and others. Danny was the founder and CTO of BindKey Technologies, an EDA corporation that was acquired by DuPont Photo masks.
About Investorideas.com - News that Inspires Big Investing Ideas https://www.investorideas.com/
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts, articles, podcasts and videos talking about cannabis, crypto, technology including AI and IoT, mining, sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, contents creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: Disclosure: GOPH is a PR, social media and publishing client and compensates Investorideas.com - More disclaimer info: shttps://www.investorideas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.
Learn more about our podcast and article services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
The AI Eye -  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com
Contact Investorideas.com
800 665 0411

No comments: